Ernest Nyarko

Ernest Nyarko is currently the Associate Director of Oncology Business Strategy at AstraZeneca, where they focus on pioneering treatments like Capivasertib and Camizestrant. Previously, Ernest worked as a Consultant and Senior Consultant in Strategy & Innovation at Deloitte and served as an Analyst for Cough, Cold & Flu at Johnson & Johnson. They briefly held a position as an Associate in Confectionery New Revenue at Nestlé. Ernest is pursuing an Honors BBA in Management & Marketing at the University of Toronto and is simultaneously studying Strategic Management at Harvard University. They also earned an MBA as a Dean's Scholar from The Johns Hopkins University in 2020.